250 related articles for article (PubMed ID: 38611024)
1. Risk-Tailoring Radiotherapy for Endometrial Cancer: A Narrative Review.
Hsieh K; Bloom JR; Dickstein DR; Shah A; Yu C; Nehlsen AD; Resende Salgado L; Gupta V; Chadha M; Sindhu KK
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611024
[TBL] [Abstract][Full Text] [Related]
2. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for advanced endometrial cancer.
Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
[TBL] [Abstract][Full Text] [Related]
4. Upfront radiotherapy with brachytherapy for medically inoperable and unresectable patients with high-risk endometrial cancer.
Gannavarapu BS; Hrycushko B; Jia X; Albuquerque K
Brachytherapy; 2020; 19(2):139-145. PubMed ID: 32061534
[TBL] [Abstract][Full Text] [Related]
5. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study No. 122.
Randall ME; Spirtos NM; Dvoretsky P
J Natl Cancer Inst Monogr; 1995; (19):13-5. PubMed ID: 7577198
[TBL] [Abstract][Full Text] [Related]
6. Uterine serous carcinoma.
Bogani G; Ray-Coquard I; Concin N; Ngoi NYL; Morice P; Enomoto T; Takehara K; Denys H; Nout RA; Lorusso D; Vaughan MM; Bini M; Takano M; Provencher D; Indini A; Sagae S; Wimberger P; Póka R; Segev Y; Kim SI; Candido Dos Reis FJ; Lopez S; Mariani A; Leitao MM; Raspagliesi F; Panici PB; Di Donato V; Muzii L; Colombo N; Scambia G; Pignata S; Monk BJ
Gynecol Oncol; 2021 Jul; 162(1):226-234. PubMed ID: 33934848
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy.
Dexter J; Lips E; DiSilvestro P
Curr Oncol Rep; 2022 Dec; 24(12):1677-1683. PubMed ID: 36417134
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy.
van den Heerik ASVM; Horeweg N; de Boer SM; Bosse T; Creutzberg CL
Int J Gynecol Cancer; 2021 Apr; 31(4):594-604. PubMed ID: 33082238
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer.
Rankins NC; Secord AA; Jewell E; Havrilesky LJ; Soper JT; Myers E
Gynecol Oncol; 2007 Aug; 106(2):388-93. PubMed ID: 17509672
[TBL] [Abstract][Full Text] [Related]
10. Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline.
Harkenrider MM; Abu-Rustum N; Albuquerque K; Bradfield L; Bradley K; Dolinar E; Doll CM; Elshaikh M; Frick MA; Gehrig PA; Han K; Hathout L; Jones E; Klopp A; Mourtada F; Suneja G; Wright AA; Yashar C; Erickson BA
Pract Radiat Oncol; 2023; 13(1):41-65. PubMed ID: 36280107
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; Colombo A; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Carinelli S; Provencher D; Hanzen C; Lutgens LCHW; Smit VTHBM; Singh N; Do V; D'Amico R; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary study of sequential multi-modality adjuvant chemotherapy and radiation for advanced endometrial cancer].
Zhang G; Suo HY; Shen XY; Zhao LJ; Wang ZQ; Kong WM; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 Feb; 54(2):103-109. PubMed ID: 30803169
[No Abstract] [Full Text] [Related]
13. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.
Harkenrider MM; Block AM; Alektiar KM; Gaffney DK; Jones E; Klopp A; Viswanathan AN; Small W
Brachytherapy; 2017; 16(1):95-108. PubMed ID: 27260082
[TBL] [Abstract][Full Text] [Related]
14. Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria.
Kong TW; Chang SJ; Paek J; Lee Y; Chun M; Ryu HS
J Gynecol Oncol; 2015 Jan; 26(1):32-9. PubMed ID: 25376915
[TBL] [Abstract][Full Text] [Related]
15. Radiation-related toxicities and outcomes in endometrial cancer: are obese women at a disadvantage?
Smits A; McGrane J; Lopes A; Kent E; Bekkers R; Massuger L; Simpson N; Galaal K
Int J Clin Oncol; 2017 Oct; 22(5):945-953. PubMed ID: 28620815
[TBL] [Abstract][Full Text] [Related]
16. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
17. Combination radiation and immunotherapy in gynecologic malignancies-a comprehensive review.
Ladbury C; Germino E; Novak J; Liu J; Horne Z; Dyer B; Glaser S
Transl Cancer Res; 2021 May; 10(5):2609-2619. PubMed ID: 35116574
[TBL] [Abstract][Full Text] [Related]
18. Personalized therapy in endometrial cancer: challenges and opportunities.
Westin SN; Broaddus RR
Cancer Biol Ther; 2012 Jan; 13(1):1-13. PubMed ID: 22198566
[TBL] [Abstract][Full Text] [Related]
19. Postoperative irradiation in endometrial cancer: still a matter of controversy.
Jereczek-Fossa BA
Cancer Treat Rev; 2001 Feb; 27(1):19-33. PubMed ID: 11237775
[TBL] [Abstract][Full Text] [Related]
20. Pattern of practice for postoperative management of endometrial cancer in Korea: a survey by the Korean Gynecologic Oncology Group and the Korean Radiation Oncology Group (KGOG 2028-KROG 2104).
Lee SU; Kim JY; Kim MK; Kim YS; Kim YJ; Eom KY; Wee CW
J Gynecol Oncol; 2023 Jul; 34(4):e54. PubMed ID: 36998224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
